HLA Class II Disparity Is Necessary and Sufficient for Induction of Effective Anti-Tumor Immunity by Donor Lymphocyte Infusion in a NOD/Scid Mouse Model for Human Acute Lymphoblastic Leukemia
Author(s):
Stevanovic, S.; Schie, M.L.J. van; Griffioen, M. (0000-0002-3001-4441); Falkenburg, J.H.F.